Navigation Links
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
Date:12/11/2013

BLUE BELL, Pa., Dec. 11, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an expert panel titled, Ovarian & Cervical Cancer – Evaluating the Role of Immunotherapy Exploring Three Approaches – Dendritic Cells, DNA Plasmids & Liposomal Delivery. Dr. Kim will discuss Inovio's DNA immunotherapy VGX-3100, which was designed to treat cervical pre-cancers and cancers, head & neck cancers, and anogenital cancers caused by human papillomavirus (HPV).

Moderated by Maxim Group Managing Director and Senior Biotechnology Analyst, Jason Kolbert, and sponsored by ProActive Capital Group, this webinar will take place on Wednesday, December 11, at 4:00 pm ET.

Access to this panel discussion can be obtained through the following link: http://bit.ly/1f5r6vT

About Cervical Cancer

Cervical cancer is the most commonly occurring cancer among women in developing countries and is the second most commonly occurring cancer amongst women worldwide. Cervical cancer currently affects 530,000 women worldwide and results in 288,000 deaths annually. According to the World Health Organization, cervical cancer is 100% attributable to human papilloma virus (HPV). Preventive vaccines such as GARDASIL® and CERVARIX® are playing an important role in limiting new HPV infections but cannot protect those already infected by HPV, which is present in an estimated 10% of the global population. In addition, a significant number of girls and women eligible for vaccination are not receiving these preventive vaccines. There is no viable therapeutic vaccine or drug to treat HPV, nor the pre-cancers and cancers caused by HPV.

About VGX-3100

VGX-3100, designed to treat HPV-caused cancers and pre-canc
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
2. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
3. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
4. St. Josephs Hospital Expands Advanced Center for Robotic Surgery in Tampa, Adds Single Site Surgery for Gallbladder Removal
5. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
6. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
7. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
8. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
9. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
10. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Europe Ultrasound Devices Market - Growth, Trends ... offering. Currently, the European market is dominated ... of France and ... increasing incidences of chronic diseases in these regions. ...
(Date:6/2/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... its common stock at a public offering price of ... of 1,764,705 shares to be sold by Nevro and ... stockholders, resulting in aggregate proceeds of approximately $90.0 million ...
(Date:6/2/2015)... 2015  University Hospitals (UH) Case Medical ... area to implant a new miniaturized, wireless monitoring ... is the first and only FDA-approved heart failure monitoring device ... used by physicians to manage heart failure., ... implanted in the pulmonary artery (PA) during a non-surgical procedure ...
Breaking Medicine Technology:European Ultrasound Devices Market Report 2015-2019 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 3UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3
... to Announce First Quarter Fiscal 2011 Financial Results -- HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
... Board: ANTXE ) today announced that it had ... to the effect that its Common Stock would be removed ... 2010. The letter indicated that FINRA took ... under the Exchange Act three times in the past two ...
Cached Medicine Technology:China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 2China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 3China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 4China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 5China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 6China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 7AcuNetx Announces Change in Trading Status 2
(Date:6/3/2015)... Unfortunately, a majority of shoes sold are ... comfort to the users throughout the year. Be it a ... the local market, the makers generally tend to put all ... often overlook comfort and health. To counter this problem and ... heads at Vay Technologies have come up with uGALE, an ...
(Date:6/2/2015)... June 03, 2015 BALTIMORE, Md. – ... write a book about wellness after being diagnosed with ... believes that through lifestyle changes which enhance health, lupus ... In “ A Wellspring for Wellness ,” she offers ... , This book provides an overview of some ...
(Date:6/2/2015)... The JK-A0100EU secure smart card keyboard is ... and healthcare. However, this keyboard can also be used ... enhance the security of their network. , The wired ... a Smart Card before allowing access to the connected ... the keyboard supports secure PIN entry. , The keyboard ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Food Lion ... its sixth annual “Thriller on the Griller” events, starting ... and South Carolina locations. Each event will raise funds ... to restoring a sense of self, restoring the family ... our military families. , Through these events, Food ...
(Date:6/2/2015)... On March 19th, 2015, LiveToBeSober.org held an informative ... Legends at Detroit’s Ford Field. Hosted by former Detroit ... goal of the conference was to raise awareness about ... benefits of effective professional rehabilitation programs. It also was ... are available to them in regards to the recent ...
Breaking Medicine News(10 mins):Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2
... proteins in drug-resistant strains of the Staphylococcus aureus ... blood cellsa key process ensuring that S. aureus ... at the National Institute of Allergy and Infectious ... Health. , S. aureus disease is a global ...
... means intervention may be more effective, researchers say , , ... early rheumatoid arthritis could be identified and enrolled in ... new type of assessment and excluded two traditional assessments, ... looked at 292 people, average age 54, seen at ...
... 6 Month Period, Nasacort AQ Did Not Cause ... Suppression in This Same Age Group, BRIDGEWATER, N.J., ... Allergy, Asthma & Immunology (ACAAI) annual meeting,suggests that the ... used safely and effectively to treat children,aged 2-5 years ...
... Four members of the same,family, who owned ... Equipment,(DME) companies and Comprehensive Outpatient Rehabilitation Facilities have,each ... Medicare fraud, Assistant,Attorney General Alice S. Fisher of ... of the Southern District of Florida announced today., ...
... CHATSWORTH, Calif., Nov. 9 Innovation Management Group,Inc. ... The Magnifier 1.50, a,low cost, full screen magnification ... designed for individuals who have extreme visual,impairments or ... a few hundred to,several thousand dollars. The Magnifier ...
... if used wisely and in the right patients, experts say ... of almost $5 billion to be paid out to those ... the drug,s maker, Merck & Co., may have hoped to ... , But, according to experts, the move has merely swung ...
Cached Medicine News:Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6Health News:Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud 2Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 3Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 4
... The AutoPulse Resuscitation System consists of ... compression assembly and a rechargeable battery pack ... LifeBand is designed for adults with weight ... of 29.9 to 51.2 inches (76 to ...
... single information technology platform, the VERICIS ... from different sites (office, clinic, hospital) ... x-ray angiography, echo, nuclear, MR, hemodynamics, ... digital record on the cardiac patient. ...
... a pocket sized bidirectional Doppler, designed for use ... and extra long cable (6 feet) are detachable ... placed outside of the sterile field, to maintain ... Doppler's features include red and green LED's in ...
... The CVS4 Complete Vascular System combines cutting edge ... a computerized peripheral vascular package available in the ... format which allows you to do vascular examinations ... to, while storing patient waveforms and data in ...
Medicine Products: